Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L

Blood

Volumn 93, Issue 1, 1999, Pages 125-139

  Taksin, Anne Laure ^b   Le Couedic, Jean Pierre ^b   Dusanter Fourt, Isabelle ^b   Massé, Aline ^b   Giraudier, Stéphane ^b   Katz, André ^b   Wendling, Françoise ^b   Vainchenker, William ^b   Casadevall, Nicole ^b   Debili, Najet ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; MALE; MEGAKARYOPOIESIS; MYELOFIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0032913316     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.1.125     Document Type: Article

References (78)

1. Castro-Malaspina H: Role of ineffective megakaryopoiesis and megakaryocyte components. Prog Clin Biol Res 154:427, 1984
2. Groopman JE: The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann Intern Med 92:857, 1980
3. Jacobson RJ, Salo A, Fialkow PJ: Agnogenic myeloid metaplasia: A clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 51:189, 1978
4. Martyre MC, Romquin N, Le Bousse-Kerdiles MC, Chevillard S, Benyahia B, Dupriez B, Demory JL, Bauters F: Transforming growth factor-β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol 88:9, 1994
5. Wang JC, Lang HD, Lichter S, Weinstein M, Bern P: Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. Br J Haematol 80:184, 1980
6. Eaves CJ, Eaves AC: Erythropoietin (EP) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood 52:1196, 1978
7. Lacombe C, Casadevall N, Varet B: Polycythemia vera: In vitro studies of circulating erythroid progenitors. Br J Haematol 44:189, 1980
8. Prchal JF, Adamson JW, Murphy S, Steinmann L, Fialkow PJ: Polycythemia vera. The in vitro response of normal and abnormal cell lines to erythropoietin. J Clin Invest 61:1044, 1978
9. Eridani S, Dudley JM, Sawyer BM, Pearson TC: Erythropoietic colonies in a serum-free system: Results in primary proliferative polycythaemia and thrombocythaemia. Br J Haematol 67:387, 1987
10. Battegay EJ, Thomssen C, Nissen C, Gudat F, Speck B: Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders. Eur J Haematol 42:321, 1989
11. Chikkapa G, Carsten AL, Chanana AD, Chandra P, Cronkite EP: Increased granulocytic, erythrocytic and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia. Am J Hematol 4:121, 1978
12. Douay L, Laporte JP, Lefrançois G, Najman A, Dupuy-Montbrun MC, Lopez M, Giarratana MC, Gorin NC: Blood and spleen haematopoiesis in patients with myelofibrosis. Leuk Res 8:725, 1978
13. Douer D, Fabian I, Cline MJ: Circulating pluripotent cells in patients with myeloproliferative disorders. Br J Haematol 54:373, 1983
14. Florensa L, Besses C, Woessner S, Sole F, Acin P, Pedro C, Sans-Sabrafen J: Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia. Leukemia 9:271, 1995
15. Han ZC, Brière J, Abgrall JF, Sensebe L, Parent D, Guern G: Characteristics of megakaryocyte colony formation in normal individuals and in primary thrombocythemia: Studies using an optimal cloning system. Exp Hematol 17:46, 1989
16. Juvonen E, Partanen S, Ruutu T: Colony formation by megakaryocytic progenitors in essential thrombocythemia. Br J Haematol 66:161, 1987
17. Juvonen E, Ikkala E, Oksanen K, Ruutu T: Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: Diagnostic value and correlation to complications. Br J Haematol 83:192, 1993
18. Mazur EM, Cohen JL, Bogart JL: Growth characteristics of circulating hematopoietic progenitor cells from patients with essential thrombocythemia. Blood 71:1544, 1988
19. Sawyer BM, Westwood NB, Pearson TC: Circulating megakaryocytic progenitor cells in patients with primary thrombocythaemia and reactive thrombocytosis: Results using a serum-deprived culture assay and a positive detection technique. Eur J Hematol 53:108, 1994
20. Rolovic Z, Basara N, Gotic M, Sefer D, Bogdanovic A: The determination of spontaneous megakaryocyte colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis. Br J Haematol 90:326, 1995
21. Kimura H, Ishibashi T, Sato T, Matsuda S: Megakaryocytic colony formation (CFU-Meg) in essential thrombocythemia : Quantitative and qualitative abnormalities of bone marrow CFU-Meg. Am J Hematol 24:23, 1987
22. Gewirtz AM, Bruno E, Elwell J, Hoffman R: In vitro studies of megakaryocytopoiesis in thrombocytotic disorders of man. Blood 61:384, 1983
23. Komatsu N, Suda T, Sakata Y, Eguchi M, Kaji K, Saito M, Miura Y: Megakaryocytopoiesis in vitro of patients with essential thrombocythaemia: Effect of plasma and serum on megakaryocytic colony formation. Br J Haematol 64:241, 1987
24. Li Y, Hetet G, Maurer A-M, Chait Y, Dhermy D, Brière J: Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF. Br J Haematol 87:471, 1994
25. Li Y, Hetet G, Kiladjan J-J, Gardin C, Grandchamp B, Brière J: Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders. Br J Haematol 92:60, 1996
26. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliot G, Izumi R, Covey T, Grouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu CT, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117, 1994
27. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang W-J, Oles KJ, Hultgren B, Solberg LA Jr, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533, 1994
28. Kaushansky K: Thrombopoietin, the primary regulator of platelet production. Blood 86:419, 1995
29. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GR, Foster DC: Murine thrombopoietin: Expression cloning, cDNA sequence and stimulation of platelet production in vivo. Nature 369:565, 1994
30. Wendung F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W: The Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571, 1994
31. Broudy V, Lin NL, Kaushansky K: Thrombopoietin (c-mpl Ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin 11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85:1719, 1995
32. Debili N, Wendling N, Katz A, Guichard J, Breton-Gorius J, Hunt P, Vainchenker W: The Mpl-Ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86:2516, 1995
33. Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M: Recombinant thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 86:2494, 1995
34. Ku H, Yonemura Y, Kaushansky K, Ogawa M: Thrombopoietin, the ligand for the Mpl receptor, synergizes with Steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87:4544, 1996
35. +) human hematopoietic cells: Novel responses to flt3-Ligand and thrombopoietin. J Exp Med 183:2551, 1996
36. Ramsfjell V, Borge OJ, Veiby OP, Cardier J, Murphy MJJ, Lymari SD, Lok S, Jacobsen SEW: Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: Distinct interactions with the ligands for c-kit and FLT3. Blood 88:4481, 1996
37. - primitive progenitor cells. Blood 88:1619, 1996
38. Nagahisa H, Nagata Y, Ohnuki T, Osada M, Nagasawa T, Abe T, Todokoro K: Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood 87:1309, 1996
39. Cohen-Solal K, Villeval JL, Titeux M, Lok S, Vainchenker W, Wendung F: Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood 88:2578, 1996
40. Stoffel R, Wiestner A, Skoda RC: Thrombopoietin in thrombocytopenic mice: Evidence against regulation of the mRNA level and for a direct regulatory role of platelets. Blood 87:567, 1996
41. Broudy VC, Lin NL, Sabath DF, Papayannopoulou T, Kaushansky K: Human platelets display high affinity receptors for thrombopoietin. Blood 89:1896, 1997
42. Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, de Sauvage FJ: Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 87:2154, 1996
43. Kuter DJ, Rosenberg RD: The reciprocal relationship of thrombopoietin (c-Mpl Ligand) to changes in the platelet mass during busulfaninduced thrombocytopenia in the rabbit. Blood 85:2720, 1995
44. Yan X-G, Lacey D, Flechter F, Hartley C, McElroy P, Sun Y, Xia M, Mu S, Saris C, Hill D, Hawley RG, McNiece IK: Chronic exposure to retroviral vector encoded MGDF (mpl-Ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 86:4025, 1995
45. Yan X-Q, Lacey D, Hill D, Chen Y, Fletcher F, Hawley RG, McNiece IK: A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl-ligand) : Reversal of disease by bone marrow transplantation. Blood 88:402, 1996
46. Villeval JL, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein SA, Cramer EM, Vainchenker W, Wendling F: High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 97:4369, 1997
47. Frey BM, Rafii S, Teterson M, Eaton D, Crystal RG, Moore MAS: Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: Insights into the pathophysiology of osteomyelofibrosis. J Immunol 160:691, 1998
48. Abina MA, Tulliez M, Lacout C, Debili N, Villeval J-L, Pflumio F, Wendling F, Vainchenker W, Haddada H: Major effects of TPO delivered by a single injection of a recombinant adenovirus on prevention of septicemia and anemia associated with myelosuppression in mice: Risk of sustained expression inducing myelofibrosis due to immunosuppression. Gene Ther 5:497, 1998
49. Souyri M, Vigon I, Penciolelli JF, Heard JM, Tambourin P, Wendling F: A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 63:1137, 1990
50. Debili N, Coulombel L, Croisille L, Katz A, Breton Gorius J, Vainchenker W: Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 88:1284, 1996
51. Pannetier C, Delassus S, Darche S, Saucier C, Kourilsky P: Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res 21:577, 1993
52. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
53. Sambrook J, Fritsch EF, Maniatis T: Analysis and Cloning of Eukaryotic Genomic DNA. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
54. Pallard C, Gouilleux F, Benit L, Cocault L, Souyri M, Levy D, Groner B, Gisselbrecht S, Dusanter-Fourt I: Thrombopoietin acivates a STAT5-like factor in hematopoietic cells. EMBO J 14:2847, 1995
55. Kiladjian JJ, El-Kassar N, Hetet G, Brière J, Grandchamp B, Gardin C: Study of the thrombopoietin receptor in essential thrombocythemia. Leukemia 11:1821, 1997
56. Buschle M, Janssen J, Drexler H, Lyons T, Anger B, Bartram CR: Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: Clonal analysis of a case characterised by a N-ras gene mutation. Leukemia 2:658, 1988
57. El-Kassar N, Hetet G, Brière J, Grandchamp B: Clonal analysis of hematopoiesis in essential thrombocythemia: Advantages of studying T lymphocytes and platelets. Blood 89:128, 1997
58. + cells. Blood 86:48, 1995
59. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L: Polycythemia vera: Stem cell and probable clonal origin of the disease. N Engl J Med 295:913, 1976
60. Casadevall N, Vainchenker W, Lacombe C, Vinci J, Chapman J, Breton-Gorius J, Varet B: Erythroid progenitors in polycythemia vera. Demonstration of their hypersensitivity to erythropoietin using serum-free cultures. Blood 59:447, 1982
61. Martyre MC, Magdelenat H, Bryckaert MC, Laine-Bridon C, Calvo F: Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 88:9, 1991
62. Alexander WS, Metcalf D, Dunn AR: Point mutations within a dimer interface homology domain of C-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J 14:5569, 1996
63. Onishi M, Mui AL-F, Morikawa Y, Cho L, Kinoshita S, Nolan GP, Gorman DM, Miyashima A, Kitamura T: Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer. Blood 88:1399, 1996
64. de La Chapelle A, Traskelin A, Juvonen E: Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci USA 90:1980, 1993
65. de La Chapelle A, Sistonen P, Lehväslaiho H, Ikkala E, Juvonen E: Familial erythrocytosis genetically linked to erythropoietin receptor gene. Lancet 341:82, 1993
66. Arcasoy MO, Degar BA, Harris KW, Forget BG: Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. Blood 89:4628, 1997
67. Turhan AG, Humphries RK, Cashman JD, Cuthbert DA, Eaves CJ, Eaves CA: Transient suppression of clonal hemopoiesis associated with pregnancy in a patient with a myeloproliferative disorder. J Clin Invest 81:1990, 1988
68. Horikawa Y, Matsumura I, Hashimoto K, Shiraga M, Kosugi S, Tadoroko S, Kato T, Miyazaki H, Tomiyama Y, Kurata Y, Matsuzawa Y, Kanakura Y: Markedly reduced expression of platelet c-mpl receptor in Essential Thrombocythemia. Blood 90:4031, 1997
69. Li J, Xia Y, Kuter DJ: Analysis of the thrombopoietin receptor (Mpl) on platelets from normal and essential thrombocythemic (ET) patients. Blood 88:545, 1996
70. Moliterno AR, Hankins WD, Spivak JL: Impaired expression of the thrombopoietin receptor by platelets from patients with Polycythemia Vera. N Engl J Med 338:572, 1998
71. Wiestner A, Schlemper RJ, van der Maas APC, Skoda RC: An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet 18:49, 1998
72. Shuai K, Halpern J, ten Hoeve J, Sawyers CL: Constitutive activation of STATS by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247, 1996
73. Vitrat N, Cohen-Solal K, Norol F, Guichard J, Cramer E, Vainchenker W, Wendung F, Debili N: Compared effect of Mpl-Ligand and other cytokines on human MK differentiation. Stem Cells 16:37, 1998 (suppl 2)
74. Ku H, Hirayama F, Kato T, Miyasaki H, Aritomi M, Ota Y, D'Andrea A, Lyman SD, Ogawa M: Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with Steel factor or the ligand for Flt3/Flk2. Blood 88:4124, 1996
75. de Sauvage FJ, Carver-Moore K, Luoh S-M, Ryan A, Dowd M, Eaton DL, Moore MW: Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 183:651, 1996
76. Kaushansky K, Broudy V, Lin N , Jorgensen MJ, McCarty J, Fox N, Zucker-Franklin D, Lofton-Dav C: Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 92:3234, 1995
77. + cells. Blood 91:830, 1998
78. Dai CH, Krantz SB, Sawyer ST: Polycythemia vera. V Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: A possible defect of phosphatase activity in polycythemia vera. Blood 89:3574, 1997